| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |